Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M González-Cao

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Semergen|September 23, 2015
[Dual antiplatelet therapy and haemoglobin level: An observational study]M P Quinteiro-Alonso, M González-Cao, C Barreales-Cardín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 9, 2006
Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacementM González Cao, G Bastarrika, J García-Foncillas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 3, 2007
Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumabM González Cao, S Viteri, C Garrán, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|November 11, 2014
Hormone receptor and HER2 status: The only predictive factors of response to neoadjuvant chemotherapy in breast cancerS Baulies, M Cusidó, M González-Cao, et al.
Journal of Clinical Pathology|January 31, 2006
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control studyD Massi, S Puig, A Franchi, et al.
Oncology|June 10, 2008
Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanomaM González-Cao, S Viteri, A Díaz-Lagares, et al.
Anticancer Research|March 14, 2007
Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanomaM González Cao, J M Auge, R Molina, et al.
Clinical and Experimental Dermatology|May 15, 2009
Prognostic value of tyrosinase reverse transcriptase PCR analysis in melanoma sentinel lymph nodes: long-term follow-up analysisM González Cao, C Badenas, J Malvehy, et al.
Actas Dermo-Sifiliograficas|July 30, 2020
Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV)R Botella-Estrada, A Boada-García, C Carrera-Álvarez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2017
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access ProgramM González-Cao, A Arance, J M Piulats, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Semergen|September 23, 2015
[Dual antiplatelet therapy and haemoglobin level: An observational study]M P Quinteiro-Alonso, M González-Cao, C Barreales-Cardín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 9, 2006
Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacementM González Cao, G Bastarrika, J García-Foncillas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 3, 2007
Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumabM González Cao, S Viteri, C Garrán, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|November 11, 2014
Hormone receptor and HER2 status: The only predictive factors of response to neoadjuvant chemotherapy in breast cancerS Baulies, M Cusidó, M González-Cao, et al.
Journal of Clinical Pathology|January 31, 2006
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control studyD Massi, S Puig, A Franchi, et al.
Oncology|June 10, 2008
Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanomaM González-Cao, S Viteri, A Díaz-Lagares, et al.
Anticancer Research|March 14, 2007
Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanomaM González Cao, J M Auge, R Molina, et al.
Clinical and Experimental Dermatology|May 15, 2009
Prognostic value of tyrosinase reverse transcriptase PCR analysis in melanoma sentinel lymph nodes: long-term follow-up analysisM González Cao, C Badenas, J Malvehy, et al.
Actas Dermo-Sifiliograficas|July 30, 2020
Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV)R Botella-Estrada, A Boada-García, C Carrera-Álvarez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2017
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access ProgramM González-Cao, A Arance, J M Piulats, et al.
Pageof 2